« Glucagon-Like Peptide-1 Receptor Agonist Treatment in Type 1 Diabetes: A Review of Current Evidence and Rationale for Use ». Canadian Diabetes & Endocrinology Today, vol. 1, nᵒ 3, octobre 2023, p. 21–26, https://doi.org/10.58931/cdet.2023.1318.